Lysosomal Rare Disorders Research and Treatment Center — Fairfax, Virginia

Lysosomal Rare Disorders Research and Treatment Center is a clinical research site located in Fairfax, Virginia, United States 22030-6066.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Lysosomal Rare Disorders Research and Treatment Center has participated in 9 clinical trials with 8 currently active.

Therapeutic areas: Gaucher Disease, Type 1, Niemann-Pick Type C Disease, Gaucher Disease Type 1.

Sponsors: Spur Therapeutics, Azafaros B.V., Prevail Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfax

Browse all research sites in Virginia · View every site in Fairfax

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lysosomal Rare Disorders Research and Treatment Center?

Lysosomal Rare Disorders Research and Treatment Center has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lysosomal Rare Disorders Research and Treatment Center conducted?

Lysosomal Rare Disorders Research and Treatment Center has 9 clinical trials on record, with 8 currently active. Their work covers Gaucher Disease, Type 1, Niemann-Pick Type C Disease, Gaucher Disease Type 1.

Is Lysosomal Rare Disorders Research and Treatment Center accredited by Crixeo Clinical Trials?

Lysosomal Rare Disorders Research and Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lysosomal Rare Disorders Research and Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.